Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Strategies targeting angiogenesis in advanced non-small cell lung cancer.

Wang J, Chen J, Guo Y, Wang B, Chu H.

Oncotarget. 2017 May 17;8(32):53854-53872. doi: 10.18632/oncotarget.17957. eCollection 2017 Aug 8. Review.

2.

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.

Wang J, Kalhor N, Hu J, Wang B, Chu H, Zhang B, Guan Y, Wu Y.

PLoS One. 2016 Oct 3;11(10):e0163397. doi: 10.1371/journal.pone.0163397. eCollection 2016.

3.

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations.

Wang J, Wang B, Chu H, Yao Y.

Onco Targets Ther. 2016 Jun 22;9:3711-26. doi: 10.2147/OTT.S106399. eCollection 2016. Review.

4.

Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.

Chu H, Zhong C, Xue G, Liang X, Wang J, Liu Y, Zhao S, Zhou Q, Bi J.

Oncol Rep. 2013 Nov;30(5):2311-5. doi: 10.3892/or.2013.2709. Epub 2013 Aug 29.

PMID:
24002698
5.

Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.

Bi J, Zhong C, Li K, Chu H, Wang B.

Biomed Res Int. 2013;2013:138785. doi: 10.1155/2013/138785. Epub 2013 Jul 30.

6.

Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.

Zhang C, Xue G, Bi J, Geng M, Chu H, Guan Y, Wang J, Wang B.

Tumour Biol. 2014 Jan;35(1):73-80. doi: 10.1007/s13277-013-1008-4. Epub 2013 Jul 20.

PMID:
23873103
7.

Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.

Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B.

Int J Mol Sci. 2013 May 10;14(5):10015-41. doi: 10.3390/ijms140510015. Review.

8.

Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.

Zhu Z, Wang B, Bi J, Zhang C, Guo Y, Chu H, Liang X, Zhong C, Wang J.

Tumour Biol. 2013 Aug;34(4):2299-308. doi: 10.1007/s13277-013-0774-3. Epub 2013 Apr 19.

PMID:
23605320
9.

Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.

Wang J, Wang B, Zhao W, Guo Y, Chen H, Chu H, Liang X, Bi J.

PLoS One. 2012;7(12):e52704. doi: 10.1371/journal.pone.0052704. Epub 2012 Dec 20.

10.

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.

Wang J, Guo Y, Wang B, Bi J, Li K, Liang X, Chu H, Jiang H.

Mol Biol Rep. 2012 Dec;39(12):11153-65. doi: 10.1007/s11033-012-2024-y. Epub 2012 Oct 11. Review.

PMID:
23054001

Supplemental Content

Loading ...
Support Center